PPTDF.US PeptiDream Inc

Healthcare Biotechnology USA Stocks
6.70 USD
Close of Nov 17, 2026
5.88 12.85
Market cap
USD 861M
P/E
-
P/B
2.83x
ROE
-6.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PPTDF.US undervalued?

Graham number

The Graham number of PeptiDream Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PeptiDream Inc fundamental analysis

No fundamental analysis for PeptiDream Inc yet.

PeptiDream Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PeptiDream Inc

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug discovery platform that integrates the technologies to synthesize highly diverse macrocyclic peptide libraries and screen for hit compounds, as well as enables rapid and efficient identification of novel hit compounds wi…

Full company profile